![Frank W. Oertel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Frank W.
Oertel is the founder of Indivumed GmbH, which was founded in 2002.
Currently, he holds the position of Member-Supervisory Board at BioAgency AG.
Actieve functies van Frank W. Oertel
Bedrijven | Functie | Begin |
---|---|---|
BioAgency AG
![]() BioAgency AG Financial ConglomeratesFinance BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Frank W. Oertel
Bedrijven | Functie | Einde |
---|---|---|
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
BioAgency AG
![]() BioAgency AG Financial ConglomeratesFinance BioAgency AG provides financing services. The company is headquartered in Hamburg, Germany. | Finance |
Indivumed GmbH
![]() Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |